Bryan, Garnier & Co's News

Sanofi: Settlement with Lilly about SoloStar litigation

BUY, Fair Value EUR103 vs. EUR102 (+22%)
News published on
September Tuesday 29, 2015


Sanofi and Lilly have settled their patent dispute in the US. As a consequence, biosimilar Lantus SoloStar will not hit the US market before mid December next year. 2016 is therefore likely to be clean of major headwinds and Sanofi is given 6 extra months to transform its Diabetes franchise.


For more information, please contact marketing@bryangarnier.com